Generic semaglutide in Canada: approval, access and Sevmia
The latest policy debate meets a practical question: which approved product can actually fill a prescription?
Search explainers, questions, and medicine profiles.
Every published article, newest first. Reporting, explainers, and practical guides on weight and metabolic health.
The latest policy debate meets a practical question: which approved product can actually fill a prescription?
An early-diabetes trial shows why glucose effects, weight changes and the end of placebo follow-up need separate attention.
An October report posting details a June decision, with cardiovascular noninferiority rather than superiority over dulaglutide.
A new study asks whether tablets can maintain weight loss after injections. The answer is not in yet.
A new diabetes trial separates a confirmatory glucose result from supportive weight estimates and a longer safety follow-up.
Running saves activity time; walking can make activity easier to repeat. The evidence supports a more useful comparison than calories per workout.
Ab workouts can train muscles, but can they target belly fat? Compare the older trials, a newer counterexample, and what regional-fat results mean.
Fasted cardio can change workout fuel use. See what small fat-loss trials show, where uncertainty remains, and how meal timing affects the decision.
How to interpret early and later weight changes, separate fat amount from fat percentage, and judge creatine against a meaningful training goal.